In conclusion, we identified RORB as a novel regulator of proteostasis in degenerating photoreceptors and present cp-asiRORB as a promising, mechanism-based therapeutic strategy for IRDs involving proteotoxic stress. Here, RORB is linked to respiratory distress syndrome in premature infants.